NCT06556433 Family-Based Financial Incentives Intervention for Smoking Cessation
| NCT ID | NCT06556433 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,312 participants |
| Start Date | 2024-09-03 |
| Primary Completion | 2028-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,312 participants in total. It began in 2024-09-03 with a primary completion date of 2028-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The current study will conduct an RCT to evaluate the effectiveness of a family-based incentive intervention with Alaska Native/American Indian families. The experimental arm will be compared to a control arm on biochemically-confirmed smoking abstinence at 6- and 12-months post-intervention.
Eligibility Criteria
Index Participant Inclusion Criteria: * Alaska Native/American Indian (ANAI) person (based on self-reported race) and reside in Alaska. * Age ≥18 years. * Self-report smoking in the past 7 days, biochemically verified with saliva cotinine ≥ 30 ng/mL (positive result based on at-home saliva swab test provided by study team). * Smoked ≥ 3 cigarettes per day over the past 3 months. * Considering or willing to make a quit attempt. * Have or will nominate one adult family member to enroll with them. * Own or have access to a mobile phone or tablet with Internet and text messaging capabilities, or will be loaned an iPad for the study duration * Willing to upload photos of self during completion of smoking status tests. * Willing to complete and sign an Internal Revenue Service (IRS) W-9 tax identification form if they wish to receive payments on the study. * Willing to provide written informed consent and participate in study-related tests and procedures. Index Participant Exclusion Criteria: * Already enrolled in the study with another family member. * Participated in a prior study phase. Family Member Participant Inclusion Criteria (regardless of smoking status or residence with the index participant): * Age ≥18 years. * Defined as family and nominated by the index participant, or have an ANAI family member who is ≥18 years and smokes that they would like to support in quitting. * Own or have access to a mobile phone or tablet with Internet and text messaging capabilities, or will be loaned an iPad for the study duration. * Willing to complete and sign an IRS W-9 tax identification form if they wish to receive payments on the study. * Willing to provide written informed consent and participate in study related tests and procedures. Both men and women, those from non-ANAI racial/ethnic groups, and those who live outside of Alaska in the United States will be eligible family member participants. Family Member Participant Exclusion Criteria: * Already enrolled with another family member. * Participated in a prior study phase. After the randomized controlled trial, qualitative interviews will be conducted with index participants, family member participants, and Alaska Tribal Health System Stakeholders to inform program implementation. Healthcare providers, cessation specialists, Elder advisors, and Tribal Health System leaders and stakeholders will be invited by the Alaska Native Tribal Health Consortium team and separately consented and interviewed.
Contact & Investigator
Christi A Patten, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06556433 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06556433 currently recruiting?
Yes, NCT06556433 is actively recruiting participants. Contact the research team at patten.christi@mayo.edu for enrollment information.
Where is the NCT06556433 trial being conducted?
This trial is being conducted at Anchorage, United States.
Who is sponsoring the NCT06556433 clinical trial?
NCT06556433 is sponsored by Mayo Clinic. The principal investigator is Christi A Patten, PhD at Mayo Clinic. The trial plans to enroll 1,312 participants.